Watch the Senate hearing: https://dai.ly/x9j0le4
Despite MMJ's full regulatory compliance and orphan drug status from the FDA, its DEA manufacturing registration (GROW MARIJUANA) remains stonewalled inside a DEA administrative court system now deemed unconstitutional under Axon and Jarkesy. Meanwhile, tribal transit networks face virtually no enforcement-exposing a hypocritical and dangerous DEA double standard.
Read More
Judge Mulrooney's decision may have handed MMJ BioPharma Cultivation a defeat inside the DEA's walls, but in doing so, he may have handed MMJ a powerful victory in federal court. The record of constitutional violations and DEA violations is now preserved - the "Axon-Jarkesy defense"is primed - and the very administrative law judge system the DEA clings to may not survive scrutiny.
Read More
Featuring lutein, zeaxanthin, alpha-lipoic acid, and quercetin, Vision Hero offers multi-pathway nutritional support for macular health, digital eye strain, and age-related visual changes.
Read More
Herbal liquid formula with mullein, eucalyptus, and cordyceps supports mucus clearance, deeper breathing, and restful sleep as part of a proactive approach to modern respiratory wellness in 2025.
Read More
Clinically dosed with standardized bergamot and hydroxytyrosol, the new Lipidene supplement offers a natural approach to lipid health and heart support aligned with 2025 wellness trends.
Read More
New report analyzes the clean nootropic formulation behind Vyvamind, detailing how each scientifically-backed ingredient supports mental clarity, focus, and sustainable cognitive performance in 2025.
Read MoreA culture change is affecting how people talk about cosmetic surgery, from popular TikToks to BBL reversals. Dr. Meegan Gruber shows why choices made with knowledge and power are becoming more critical.
Read More
The FDA-cleared BloodVitals device leverages advanced optical sensor technology to deliver instant blood sugar, pulse, and oxygen readings-without skin penetration, test strips, or daily discomfort.
Read More
Mipletamig-driven clinical validation of the CRIS-7 derived CD3-binding domain underpins Aptevo's expansion from hematologic to solid tumors
New candidate APVO455 targets Nectin-4+ cancers, joins mipletamig (AML) and APVO442 (prostate) in Aptevo's tumor-directed CD3 suite
Read More
Formulated with antioxidant-rich nutrients and nano-delivery technology, LuminEye aims to support visual clarity, eye hydration, and night vision comfort without synthetic additives.
Read More
This collaboration underscores CliniOps' continued mission to transform clinical research through smart technologies, enabling equitable access, operational efficiency, and robust data quality, even in hard-to-reach geographies.
Read More
Judge Mulrooney's ruling epitomizes the DEA's institutional resistance to cannabis reform, prioritizing bureaucratic obstruction over public health and constitutional rights. As MMJ fights back in federal court, the case exposes a system rigged against progress-one where patients, science, and fairness are collateral damage in the failed DEA war on marijuana research.
Read More
Formulated with lutein, zeaxanthin, bilberry, and saffron, the plant-based iGenics supplement delivers targeted nutritional support for digital eye strain, blue light exposure, and long-term macular wellness.
Read More
HealthRX's direct-access platform eliminates insurance roadblocks by offering overnight delivery of doctor-prescribed GLP-1 weight loss medications like Ozempic® and semaglutide-backed by licensed physicians, transparent pricing, and real results.
Read MoreStudy used cell lines obtained from the Progeria Research Foundation to evaluate Telomir-1's effects on key drivers of accelerated aging
Read More85% remission rate observed in evaluable frontline AML patients
Mipletamig combination enables rare pathway to transplant in a previously ineligible unfit patient
No dose-limiting toxicities observed among evaluable patients; safety profile remains strong
Evidence mounts for mipletamig as a potentially transformational addition to standard of care in frontline AML as targeted CD123 x CD3 approach showing power and precision, limited added toxicity
Mipletamig Trial Momentum Builds as Cohort 3 Nears Full Enrollment at highest dose level evaluated to date in combination therapy
Read MoreRegulatory Approval by the UK Financial Conduct Authority was Key Requirement for Transaction Timing
Minimal Conditions Remain for Deal Completion; Closing Expected in July, 2025
Read More
With more than 10,000 procedures performed, Dr. Naderi discusses the technical demands and aesthetic advantages of non-surgical rhinoplasty using dermal fillers.
Read More
Illegal THC on every corner, Illegal grow ops in plain sight, Yet the DEA continues to block MMJ BioPharma Cultivation's FDA sanctioned application to produce pharmaceutical-grade cannabis pending since 2018.
Read MoreNew subsidiary, Cynaptec Pharmaceuticals, established to hold global rights to Conjugated Psilocin™
$6 million investment in Cynaptec Pharmaceuticals secured to advance research and early-stage clinical trials for chronic cluster headaches and addiction
Option for an additional $20 million investment in Cynaptec Pharmaceuticals to support Phase 3 clinical development
Explore the natural formula behind Blood Pressure 911-PhytAge Laboratories' most trusted supplement for promoting heart health, improving circulation, and supporting healthy blood pressure levels in 2025.
Read MoreRevenues increased 9% in Q4 2025 compared to Q4 2024, and 12% in FY 2025 compared to FY 2024
Net loss improved 27% in Q4 2025 compared to Q4 2024, and 29% in FY 2025 compared to FY 2024
EBITDA loss improved 59% in Q4 2025 compared to Q4 2024, and 17% in FY 2025 compared to FY 2024
Ainos Hits Inflection Point with AI Nose Pilot Ramp in Senior Care, Robotics, and Semiconductors
Key VELDONA® Human Clinical Studies Secure Taiwan Regulatory Greenlight, Accelerating Development
Read More
Quilt Health expands its mission to streamline clinical trial recruitment, enhance patient access to therapies and strengthen provider networks for sickle cell disease
Read More
Desert Oasis Healthcare has been named Large Business of the Year by the Greater Coachella Valley Chamber of Commerce, recognizing the organization’s exceptional leadership, innovation, and unwavering commitment to the health and well-being of the communities it serves.
Read More
Innovative New Metrics Enable Precise Vendor Assessment, Reflecting AI Adoption, Strategic Outsourcing, and Financial Stability Amid Regulatory and Economic Shifts
Read More
Younger People are Leading a Cultural Shift Toward Small, Natural-Looking Changes, Such as Baby Botox and Mini Facelifts, and Gruber Plastic Surgery is Ready to Meet the Demand
Read MoreNational Leaders in Hospital Genomic Surveillance Join in Key Advisory Roles as NGD Prepares to Deploy Real-Time Sequencing-Based Detection of Transmission in Hospitals
Read More
Comprehensive Rankings Leveraging Innovative KPIs Including AI Integration, Outsourcing Capabilities and Financial Resilience to Provide the Definitive Methodology for True Client Satisfaction in RCM
Read More
Read More"The era of rogue DEA regulators must end," said Duane Boise. "If DEA administrator nominee wants to restore credibility, he must start by naming and removing the Biden-era ‘Do-Nothing' team."